Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7974

1.

Cognitive reserve and lifestyle: moving towards preclinical Alzheimer's disease.

Arenaza-Urquijo EM, Wirth M, Chételat G.

Front Aging Neurosci. 2015 Aug 10;7:134. doi: 10.3389/fnagi.2015.00134. eCollection 2015. Review.

2.

[PET with amyloid ligands should not be applied routinely in early diagnostics of Alzheimer's disease].

Hasselbalch SG.

Ugeskr Laeger. 2015 Aug 3;177(32). pii: V11140610. Danish.

PMID:
26321582
3.

Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.

Ota K, Oishi N, Ito K, Fukuyama H; SEAD-J Study Group;Collab; Alzheimer's Disease Neuroimaging Initiative;Collab.

J Neurosci Methods. 2015 Aug 26. pii: S0165-0270(15)00311-8. doi: 10.1016/j.jneumeth.2015.08.020. [Epub ahead of print]

PMID:
26318777
4.

Identification of Alzheimer's disease-associated long noncoding RNAs.

Zhou X, Xu J.

Neurobiol Aging. 2015 Jul 16. pii: S0197-4580(15)00372-3. doi: 10.1016/j.neurobiolaging.2015.07.015. [Epub ahead of print]

PMID:
26318290
5.

Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.

Nayak A, Salt G, Verma SK, Kishore U.

Int Rev Neurobiol. 2015;121:59-86. doi: 10.1016/bs.irn.2015.05.003. Epub 2015 Jun 19.

PMID:
26315762
6.

The Potential of Proteomics in Understanding Neurodegeneration.

Pal R, Larsen JP, Moller SG.

Int Rev Neurobiol. 2015;121:25-58. doi: 10.1016/bs.irn.2015.05.002. Epub 2015 Jun 19.

PMID:
26315761
7.

Alzheimer's Disease: Genomics and Beyond.

Song F, Han G, Bai Z, Peng X, Wang J, Lei H.

Int Rev Neurobiol. 2015;121:1-24. doi: 10.1016/bs.irn.2015.05.001. Epub 2015 Jun 19.

PMID:
26315760
8.

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature.

Simonsen AH, Kuiperij B, Ali El-Agnaf OM, Engelborghs S, Herukka SK, Parnetti L, Rektorova I, Vanmechelen E, Kapaki E, Verbeek M, Mollenhauer B.

Biomark Med. 2015 Aug 28. [Epub ahead of print]

PMID:
26314196
9.

Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.

Ye T, Zu C, Jie B, Shen D, Zhang D; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2015 Aug 27. [Epub ahead of print]

PMID:
26311394
10.

Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease.

de Flores R, La Joie R, Chételat G.

Neuroscience. 2015 Aug 22. pii: S0306-4522(15)00765-4. doi: 10.1016/j.neuroscience.2015.08.033. [Epub ahead of print] Review.

PMID:
26306871
11.

Biomarkers in Alzheimer's disease: understanding disease trajectory and therapeutic targets.

Peall KJ, Robertson NP.

J Neurol. 2015 Aug 25. [Epub ahead of print] No abstract available.

PMID:
26303833
12.

Brain targeted PLGA nanocarriers alleviating amyloid-Β expression and preserving basal survivin in degenerating mice model.

Sriramoju B, Neerati P, Kanwar RK, Kanwar JR.

Biochim Biophys Acta. 2015 Aug 21. pii: S0925-4439(15)00242-2. doi: 10.1016/j.bbadis.2015.08.015. [Epub ahead of print]

PMID:
26303642
13.

Dissociation of amyloid biomarkers in PET and CSF in Alzheimer's disease: a case report.

Schroeter ML, Tiepolt S, Marschhauser A, Thöne-Otto A, Hoffmann KT, Barthel H, Obrig H, Sabri O.

BMC Neurol. 2015 Aug 26;15:152. doi: 10.1186/s12883-015-0410-5.

14.

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's Disease.

Paquet C, Dumurgier J, Hugon J.

Front Neurol. 2015 Aug 4;6:168. doi: 10.3389/fneur.2015.00168. eCollection 2015. Review.

15.

Imaging biomarkers in tauopathies.

Dani M, Edison P, Brooks DJ.

Parkinsonism Relat Disord. 2015 Aug 14. pii: S1353-8020(15)00343-0. doi: 10.1016/j.parkreldis.2015.08.011. [Epub ahead of print]

PMID:
26299160
16.

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.

Liu Y, Tan L, Wang HF, Liu Y, Hao XK, Tan CC, Jiang T, Liu B, Zhang DQ, Yu JT; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2015 Aug 23. [Epub ahead of print]

PMID:
26298664
17.

Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patients.

Rubio-Perez JM, Albaladejo MD, Zafrilla P, Vidal-Guevara ML, Morillas-Ruiz JM.

Eur J Nutr. 2015 Aug 23. [Epub ahead of print]

PMID:
26298312
18.

Advances in the treatment of cognitive impairment in Parkinson's disease.

Goldman JG, Weintraub D.

Mov Disord. 2015 Aug 22. doi: 10.1002/mds.26352. [Epub ahead of print]

PMID:
26297863
19.

How many biomarkers to discriminate neurodegenerative dementia?

Sancesario GM, Bernardini S.

Crit Rev Clin Lab Sci. 2015 Aug 18:1-13. [Epub ahead of print]

PMID:
26292074
20.

Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia.

Huang CW, Tsai MH, Chen NC, Chen WH, Lu YT, Lui CC, Chang YT, Chang WN, Chang AY, Chang CC.

Thromb Haemost. 2015 Aug 20;114(6). [Epub ahead of print]

PMID:
26289958
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk